What is String Bio?
String Bio is focused on delivering cost-effective, robust, and sustainable solutions by revolutionizing waste management. The company's core innovation lies in leveraging methane, derived from waste or natural sources, to produce valuable chemical monomers. These monomers serve as foundational elements for creating a wide array of everyday products, from biodegradable plastics to high-performance polymers essential for medical applications like stents and sutures. This approach enables String Bio to establish circular value chains for organic waste, methane, and plastics, addressing critical environmental and industrial needs.
How much funding has String Bio raised?
String Bio has raised a total of $20M across 1 funding round:
Series B
$20M
Series B (2022): $20M, investors not publicly disclosed
What's next for String Bio?
The recent major strategic investment signifies a pivotal moment for String Bio, likely enabling the company to scale its operations, expand its technological capabilities, and accelerate market penetration. With a clear vision to transform waste streams into valuable chemical building blocks, String Bio is well-positioned to capitalize on the growing demand for sustainable materials and circular economy solutions. Future developments may include strategic partnerships, further technological advancements in methane conversion, and the expansion of its product portfolio to address a broader range of industrial applications.
See full String Bio company page
